BHEL in Focus After Q2 Results, Brokerage Views and Order Inflow Concerns | 16 October 2026
BHEL in focus ahead of market open after reporting Q2 profit growth alongside muted order inflows and cautious brokerage views. Check key technical levels.
TCS in Focus Today on BBY Services Acquisition and AI Foundry Launch | 16 October 2026
TCS is in focus ahead of the market open following the completion of BBY Services India LLP acquisition and the launch of Industrial Intelligence Foundry.
SBI Cards in Focus After Launching Co-Branded Eternal SBI Card | 16 October 2026
SBI Cards is in focus following the launch of the co-branded Eternal SBI Card in partnership with Eternal, featuring discounts on Zomato, Blinkit, and Uber.
Power Finance Corporation in Focus on RBI Merger Clearance and New Subsidiary | 16 October 2026
Power Finance Corporation in focus ahead of the market open after receiving RBI no-objection for the REC Limited merger and forming a new transmission.
HDFC Life in Focus After H1 FY27 Results and GIFT City Office Plan | 16 October 2026
HDFC Life reports H1 FY27 financial results with 13% PAT growth, board approval for ₹500 crore NCD issuance, and GIFT City expansion plans.
Crompton Greaves Consumer Electricals in Focus After Management Shift | 16 October 2026
Crompton Greaves Consumer Electricals in focus following senior management internal transition and a minor consumer forum order. Check pre-market details.
360 ONE WAM in Focus: Interim Dividend and Monitoring Agency Reports | 16 October 2026
360 ONE WAM Limited in focus ahead of market open after declaring a ₹7.50 interim dividend and releasing preferential issue monitoring agency reports.
Persistent Systems in Focus Today on Q2 Revenue and Nagarro Stake | 16 October 2026
Persistent Systems reports Q2 FY27 revenue of $487.6M and secures a 94.04% stake in Nagarro. Track pre-market updates and technical context for trading.
Mankind Pharma in Focus After Acquiring Majority Stake in Armed Cell Therapeutics | 16 October 2026
Mankind Pharma stock in focus pre-market after approving a 70% stake acquisition in Armed Cell Therapeutics for CAR-T cancer therapies and receiving an ESG.
L&T Finance in Focus After Reporting Record Q2 FY27 Profit of ₹975 Crore | 16 October 2026
L&T Finance in focus after posting a record Q2 FY27 net profit of ₹975 Crore and strong retail book growth. Check key financial metrics and earnings highlights.